2AuE.Tan EH.Ang PT Activity of Paclitaxel by three-hour intusion in Asian Patients with metastatic undifferentiated nasopharyngeal cancer[J].Ann Pncol,1998,9(3):327-329 被引量：1
3Yeo W,leung TW,Chan AT.etal.A phase ⅡStady of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma[J].Eur J Cancer,1998,34(13):2027 被引量：1
4Jean-Pierre Pignor,Nathalie Syz.Marshau Posner,etal,Adjwting For Paticont selelt:on suggese the addition of doletaxel to tfluorour-cilcisplatin induct:on therapy may offor wurvial benef:t in Sguamous Cell canler of the hed and erlk[J].Ant:camcer Drugs,2004,(15):331-340 被引量：1
5H,T sutuda M,Mochim atu I,etal,Phase Ⅰer:al of cor wrrent Chem.oradiotherapy with docetaxal cisplatin and 5-fguo-rouracil (OPF)in patients with louay advanced sguom ous cou Carvinoma of the Head and neck(cllHN)[J].BrJanler,2004,90 (2):348-352 被引量：1
6M.ccarthy S,Tannock F,Degerdorfev P.A phaseⅡ trial of clocetaxel And cisplatin in patients with recurrent or metastaic.Asopheryngeal Carcinoma[J].Oral Oncal,2002,38 (7):686-690 被引量：1
6Brigette B. Y.Ma,Anthony T. C.Chan.Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma[J].Cancer.2004(1) 被引量：1
7Li, Xiao-Dong,Luo, Wen-Jian,Yao, Xin.Preface[J].Journal of Computer Science & Technology,2008,23(1):1-1. 被引量：223
